To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

NCT02490774 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

174

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception

Interventions

DRUG: BAY1007626
DRUG: Jaydess
DRUG: Mirena

Sponsor

Bayer